Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Krishna Institute of Medical Sciences has informed that Dr. Bhaskara Rao Bollineni - Founder & Managing Director, Dr. Abhinay Bollineni - Executive Director and CEO, and Sachin Salvi - Chief Financial Officer, would participate in a conference call with analysts and investors, being hosted by IIFL Capital on Monday 10th November 2025, at 9:00 am IST, to discuss the company’s business strategy and outlook post the declaration of Q2FY26 financial results. A copy of the invite for the conference call, as being circulated by the host, is enclosed.
The above information is a part of company’s filings submitted to BSE.
